Back
March 25, 2026

From Breakthrough to Breakdown. When Immunity Loses Its Focus

Voice for Science and Solidarity by Geert Vanden Bossche is a reader-supported publication. To receive new posts and support my work,consider becoming a free or paid subscriber.

From Breakthrough to Breakdown. When Immunity Loses Its Focus

Immune Refocusing as the Missing Link Between Viral Gain-of-Function and Host Immune Loss-of-Function, Bridging Persistent Immune Escape and Long COVID

Executive Summary

Chronic viral sequelae do not necessarily involve persistent high viral loads and can arise from suboptimal adaptive population-level immunity, such as that induced by the mass COVID-19 (C-19) vaccination program during the SARS-CoV-2 pandemic.

Suboptimal collective immunity sustains viral transmission in highly C-19-vaccinated populations, thereby shifting viral evolution toward immune escape–driven gain-of-function.

This, in turn, drives repeated immune refocusing and dysregulation, progressively eroding coherent antiviral control.

The resulting metastable host-pathogen interactions enable vaccine-breakthrough infections, persistent immune escape, prolonged viral shedding, and long COVID.

The prevalence of long COVID may therefore correlate with the intensity and frequency of ongoing transmission, and consequently with the likelihood that the virus may abruptly transition toward a highly adapted, immune-evasive lineage (HiViCron).


Immune Refocusing–Mediated Chronic Infection: a Phase-Transition Perspective

A subset of viral infections may transition into a chronic or relapsing state, not primarily because of sustained high-level viral replication but as a consequence of suboptimal adaptive immune responses driving viral immune escape and, thereby, repeatedly ‘refocusing’ the host’s adaptive immune effector activity and compromising population-level antiviral control.

In this framework, chronicity emerges from a metastable host-pathogen equilibrium characterized by intermittent, low-level viral transmission accompanied by recalled but poorly functional adaptive immune memory.
Rather than exerting collective sterilizing immune pressure on highly vulnerable viral targets, immune responses in highly C-19-vaccinated populations have been progressively redirected toward more conserved but subdominant epitopes as a result of selective immune pressure largely exerted by preceding large-scale vaccine-mediated immune priming. This continual reorientation undermines effective viral clearance while perpetuating the reactivation of misdirected immune responses.

This mechanism integrates directly with the evolutionary trajectory outlined in my previous Substack article (https://voiceforscienceandsolidarity.substack.com/p/why-the-current-calm-in-sars-cov):

as long as viral transmission continues at scale, the virus remains engaged in an ongoing process of exploration within a constrained fitness landscape.

However, in highly vaccine-experienced populations, this exploration becomes increasingly shaped by immune pressure rather than by unconstrained optimization of transmissibility.
Viral gain-of-function is therefore no longer primarily expressed as increased intrinsic infectiousness, but as an enhanced capacity of the virus to evade, exploit, and redirect host immunity. Immune refocusing lies at the core of this shift, as suboptimal population-level immune pressure selects for escape variants, while immune escape in turn forces the host response to repeatedly recalibrate –progressively eroding its functional integrity.

Crucially, this dynamic is governed by a feedback loop between viral adaptation and population-level immune conditioning. Each round of immune pressure accelerates and shapes viral evolution, while each newly adapted variant readily reshapes the immune landscape it challenges. As this loop intensifies under sustained transmission, it does not simply amplify –it begins to close, as feedback loops ultimately operate within an increasingly constrained fitness landscape. As previously explained, the system becomes increasingly volatile, i.e., more prone to instability, as reflected by the emergence of highly mutated, immune-evasive variants that neither rapidly dominate nor disappear (https://voiceforscienceandsolidarity.substack.com/p/why-the-current-calm-in-sars-cov).
Instead, these variants signal that the virus is probing and exploring new ways to traverse an increasingly constricted evolutionary bottleneck –a biological ‘Strait of Hormuz’–where only highly adapted configurations may enable qualitatively different interactions with the enemy’s defense (i.e., the host immune system).

From a phase-transition perspective, this dynamic reflects the gradual destabilization of a previously adaptive equilibrium between host and pathogen. As immune escape intensifies and immune refocusing becomes more frequent and less effective, the system approaches a critical threshold at which incremental viral adaptations may produce disproportionate biological consequences in highly C-19-vaccinated populations.
It is within this unstable regime that the emergence of a highly immune-evasive and potentially highly virulent lineage –conceptualized as HiViCron– becomes plausible. Such a transition may require additional time, as it will likely result from the cumulative outcome of sustained immune misdirection and viral adaptation under persistent transmission pressure.

Importantly, this same mechanism provides a coherent explanation for the increasing prevalence of long COVID. In a subset of individuals, persistent viral replication hubs or residual viral antigens are insufficiently cleared and continue to stimulate an immune response that is functionally incoherent and repeatedly redirected upon infectious re-exposure. Rather than resolving, the immune system oscillates between insufficient antiviral efficacy and maladaptive inflammatory signaling, resulting in chronic, multisystem symptomatology.

Crucially, the probability of entering this state is not independent of the epidemiological context. The continued circulation of evolving viral variants increases the frequency with which the immune system is challenged, redirected, and potentially destabilized. In this sense, the prevalence of long COVID may scale –at least in part– with the intensity and persistence of viral transmission, reflecting not merely cumulative exposure, but the cumulative burden of immune refocusing events.

Vaccine breakthrough infections, persistent immune escape, and long COVID in highly C-19-vaccinated populations should therefore not be regarded as separate phenomena, but as interconnected manifestations of a single underlying syndrome.
This syndrome is defined by the progressive decoupling of immune recognition from effective viral control, driven by the co-evolution of viral gain-of-function and host immune loss-of-function.
Chronicity, in this context, is not an anomaly of the virus, which typically causes acute, self-limiting infection, but an emergent property of an immune system that has lost its natural focus.


Closing Perspective

If this framework holds, it challenges a deeply ingrained assumption:
that increasing population-level immunity will necessarily converge toward protective herd immunity and stable viral control.
Instead, under conditions of sustained transmission and repeated immune engagement, immunity itself may become progressively destabilized–its protective function diluted by continuous refocusing and functional drift driven by fitness-based selection pressure.

What begins as a feedback loop between viral adaptation and immune conditioning may ultimately evolve into a closed, self-reinforcing system–one that no longer trends toward equilibrium, but toward instability. In such a system, the boundary between protection and pathology becomes increasingly blurred, and the distinction between acute infection and chronic disease progressively erodes.

The implications are both conceptual and practical-and so too are the lessons for our public health authorities and so-called ‘experts’:

controlling viral spread is not merely about reducing acute disease burden, but about preventing the progressive erosion of immune coherence at the population level
.

Failing to do so is reckless, as it risks locking the host-pathogen relationship into a cycle of immune escape, misdirected immunity, and chronic disease, potentially culminating in a phase transition toward a qualitatively different and more pathogenic equilibrium, with a potentially disastrous outcome for public, or even global health.

In that light, long COVID is not simply a lingering aftermath.
It may be better understood as an early warning signal of a system that is no longer capable of resolving infection efficiently, but is instead learning –repeatedly and imperfectly– how to chase a moving target and escape a constrained viral landscape.
The longer the virus’ learning process persists, the higher the expected prevalence of long COVID and the greater the likelihood the virus crosses the threshold toward a highly virulent lineage (HiViCron).

It all makes a great deal of sense, not only from a biological but even from a philosophical perspective, as it is difficult to conceive that nature would simply proceed with an increasingly debilitated population (i.e., affected by long COVID).

Yet, remarkably, there is little to no serious scientific debate on the underlying mechanisms of this derailed immune escape pandemic. Those who might be expected to confront it instead appear more inclined to deflect, ignore, or outright deny the threatening evolutionary dynamics of what increasingly resembles a large-scale gain-of-function experiment, thereby leaving entire populations exposed and dangerously unprepared.

Support our work
DONATE
Subscribe to our Substack Newsletter

Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.

Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.

Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.

Email: info@voiceforscienceandsolidarity.org

Recent Posts
May 5, 2026

When Linear Thinking Fails - Simplified Version

Read
May 5, 2026

When Linear Thinking Fails

Read
April 23, 2026

When Confusion Masquerades as Insight: Misreading BA.3.2

Read
Voices for Science and solidarity, © 2023